A detailed history of Accent Capital Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Accent Capital Management, LLC holds 100 shares of PRCT stock, worth $6,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 188 46.81%
Holding current value
$6,515
Previous $15.1 Million 46.54%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$67.27 - $99.45 $5,919 - $8,751
-88 Reduced 46.81%
100 $8.05 Million
Q3 2024

Nov 06, 2024

BUY
$56.31 - $84.99 $10,586 - $15,978
188 New
188 $15.1 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.91B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.